Antimicrobial use and combination of resistance phenotypes in bacteraemic Escherichia coli in primary care: a study based on Japanese national data in 2018.
Yumiko HosakaYuichi MurakiToshiki KajiharaSayoko KawakamiAki HirabayashiMasahiro ShimojimaHiroki OhgeMotoyuki SugaiKoji YaharaPublished in: The Journal of antimicrobial chemotherapy (2023)
Significant AMU, specifically of oral third-generation cephalosporins and fluoroquinolones, in clinics is associated with a higher prevalence of E. coli isolates resistant to both drugs. This study provides a basis for national interventions to reduce inappropriate AMU in primary care settings.